Back to results

CompletedPhase 2

Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease

NCT03363269

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Dong-A University Hospital

Busan, South Korea

+19 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2016-04-12
Enrollment: 116 participants
Sponsor: IlDong Pharmaceutical Co Ltd
Purpose: treatment

Locations (20)

Dong-A University HospitalBusan, South Korea
Changwon Fatima HospitalChangwon, South Korea
Kangwon National University HospitalChuncheon, South Korea
Daegu Catholic University Medical CenterDaegu, South Korea
Kyungpook National University Chilgok HospitalDaegu, South Korea
Yeungnam University Medical CenterDaegu, South Korea
Daejeon Eulji Medical Center, Eulji UniversityDaejeon, South Korea
Myongji HospitalGoyang, South Korea
Hanyang University Guri HospitalGuri-si, South Korea
Chonnam National University HospitalGwangju, South Korea
Inha University HospitalIncheon, South Korea
Chonbuk National University HospitalJeonju, South Korea
Seoul National University Bundang HospitalSeongnam-si, South Korea
Chung-Ang University HospitalSeoul, South Korea
Ewha Womans University Mokdong HospitalSeoul, South Korea
Hanyang University HospitalSeoul, South Korea
Korea University Anam HospitalSeoul, South Korea
KunKuk University HospitalSeoul, South Korea
Ajou University Medical CenterSuwon, South Korea
Pusan National University Yangsan HospitalYangsan, South Korea